Prolonged Disease-Free Survival after Autografting for Chemosensitive Non-Bulky Low Grade Non-Hodgkin's Lymphoma

References

• Dana B. W., Dahlberg S., Nathwani B. N., Chase E., Coltman C., Miller T. P., Fisher R. I. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemo-immunotherapy. Journal of Clinical Oncology 1993; 11: 644–651
   PubMed Web of Science ®Google Scholar
• Mounier N., Gisselbrecht C. Prognostic factors in follicular lymphoma: a clinical and methodologic challenge. Haematologica 1999; 84(suppl. to n. 10)15–17
   Google Scholar
• Weisdorf D. J., Andersen J. W., Glick J. H., Oken M. M. Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation. Journal of Clinical Oncology 1992; 10: 942–947
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Neuberg D., Mauch P., Soiffer Anderson R. J.K.C., Fisher D. C., Schlossman R., Alyea E. P., Takvorian T., Jallow H., Kuhlman C., Ritz J., Nadler L. M., Gribben J. G. Long-term follow-up of autologous bone marrow transplantation in patients, with relapsed follicular lymphoma. Blood 1999; 94: 3325–3333
   PubMed Web of Science ®Google Scholar
• Bierman P. J., Vose J. M., Anderson J. R., Bishop M. R., Kessinger A., Armitage J. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. Journal of Clinical Oncology 1997; 15: 445–450
   PubMed Web of Science ®Google Scholar
• Bastion Y., Brice P., Haioun C., Sonet A., Salles G., Marolleau J. P., Espinouse D., Reyes F., Gisselbrecht C., Coiffier B. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 86: 3257–3262
   PubMed Web of Science ®Google Scholar
• Rohatiner A. Z., Johnson P. W., Price C. G., Arnott S. J., Amess J. A., Norton A. J., Dorey E., Adams K., Whelan J. S., Matthews J. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. Journal of Clinical Oncology 1994; 12: 1177–1181
   PubMed Web of Science ®Google Scholar
• Cervantes F., Shu X. O., McGlave Ramsay P. B.N.K., Miller W. J., Kersey J. H., Weisdorf D. J. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant. 1995; 16: 387–392
   PubMed Web of Science ®Google Scholar
• Colombat P., Donadio D., Fouillard L., Milpied N., Tilly H., Pico J., Abgrall J. F., Coiffier B., Herbrecht R., Philip T. Value of autologous bone marrow transplantation ill follicular lymphoma: a France Autogreffe retrospective study of 12 patients. Bone Marrow Transplant 1994; 13: 157–162
   PubMed Web of Science ®Google Scholar
• Tarella C., Caracciolo D., Corradini P., et al. High-dose chemotherapy with PBPC autograft in low grade non-Hodgkin's lymphoma. Haematologica 1999; 84(suppl. to no. 10)44–40
   PubMedGoogle Scholar
• Gribben J. G., Freedman A. S., Neuberg Roy D. DC, Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. J. Immunologic purging of marrow assessed by PCR before autologous hone marrow transplantation for B-cell lymphoma. New England Journal of Medicine 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Stone K. M., Neuberg D., Takvorian R., Soiffer T., Whelan M., Rabinowe S. N., Aster J. C., Leavitt P., Mauch P., Anti Freedman A. S. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for iron-Hodgkin's lymphoma. Journal of Clinical Oncology 1994; 12: 2535–7542
   PubMed Web of Science ®Google Scholar
• Grigg A. P., Goss G. Phase I dose-escalation s ot 5 day continuous infusion VP16 plus busulphan-cyclophosphamide as a conditioning regimen prior to autologous transplantation. Blood 1994; 84: 826a, October 1995(abst) and (updated) VIII Congress of the Asian-Pacific Division of the International Society of Haematology
   Google Scholar
• Grigg A., Chapman R., Szer J. Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine. Bone Marrow Transplantation 1998; 21: 619–621
   PubMed Web of Science ®Google Scholar
• Hochster H. S., Kim K. M., Green M. D., Mann R. B., Neiman R. S., Oken M. M., Cassileth P. A., Stott P., Ritch P., O'Connell M. J. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study. Journal of Clinical Oncology 1992; 10: 3–32
   PubMedGoogle Scholar
• McLaughlin P., Hagemeister F. B., Shan F. J.C., Cabanillas F., Pate O., Romaguera J. E., Rodriguez M. A., Redman J. R., Keating M. Phase I study of the combination of fludarabine, mitoxantroe and dexamethasone in low-grade lymphoma. Journal of Clinical Oncology 1994; 12: 575–579
   PubMed Web of Science ®Google Scholar
• Seymour J. F., Grigg A. P., Szer J., Bardy P., Whitehead S., Fox R. M. Fludarabine and mitoxantrone, a highly effective and well-tolerated salvage therapy for low grade lymphoproliferative disorders. Blood 1997; 90: 343a, abst
   Google Scholar
• McLaughlin P., Grillo-Lopez A. J., Link R. K., Levy R., Czuczman M. S., Williams M. E., Heyman M. R., Bence-Bruckler I., White C. A., Cabanillas Jain E. V., Ho A. D., Lister J., Wey K., Shen D., Dallaire B. K. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology 1998; 16: 2825–2833
   PubMed Web of Science ®Google Scholar
• van Besien K., Sobocinski K. A., Rowlings P. A., Murphy S. C., Armitage J. O., Bishop M. R., Chaekal O. K., Gale R. P., Klein J. P., Lazarus H. M., McCarthy P. L., Jr, Rae-Maekers J. M., Reiffers J., Phillips G. L., Schattenberg A. V., Verdonck L. F., Vose J. M., Horowitz M. M. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 1996; 92: 1832–1836
   Web of Science ®Google Scholar
• Freedman A. S., Gribben J. G., Neuberg D., Mauch P., Soiffer R. J., Anderson K. C., Pandite L., Robertson M. J., Kroon M., Ritz J., Nadler L. M. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996; 88: 2780–2786
   PubMed Web of Science ®Google Scholar
• Harrison C. N., Ruiz de Elvira M. C., Taghipour G., Schmitz N., Goldstone A. H. When is a patient “cured” following ABMT/PBSCT? An analysis of ABMT/PBSCT in NHL from the EBMT suggests that patients with low grade lymphoma may not he “cured” with ABMT/PBSCT. Blood 1999; 94: 170a, (abst)
   Web of Science ®Google Scholar
• Molina A., Nademanee A., O'Donnell M. R., Snyder D. S., Fung H. C., Frankel P., Dagis A., Stein A. S., Parker P. M., Kashyap A. K., Spielbnerger R. T., Somlo G., Vora N., Sniecinski I., Niland J., Forman S. J. Long-term follow-up and analysis of prognostic factors after high-dose therapy and peripheral blood stem cell autografting in 58 patients with a history of low grade follicular lymphoma. Blood 1999; 94: 171a, abst
   Web of Science ®Google Scholar
• Bastion Y., Berger F., Byron P. A., Felman P., Ffrench M., Coiffier B. Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years. Annals of Oncology 1991; 2(suppl 2)123–129
   PubMed Web of Science ®Google Scholar
• Williams C. D., Goldstone A. H., Pearce R. M., Philip T., Hartmann O., Colombat P., Santini G., Foulard L., Gorin N. C. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. Journal of Clinical Oncology 1996; 14: 2454–2464
   PubMed Web of Science ®Google Scholar
• Bosly A., Radford J., Salles G., Grigg A., Lopez-Guillermo A., Barbui T., Trneny M., Holte H., Hagberg H., Sebban C., Leal da Costa F., Colombat P., Bron D., Tilly H., Sweetenham J. W., Kolstad A., Rapoport B. L., Haioun C., Fontan J., Sonet A., Lafleur F., Coiffier B. Interferon α2b versus no treatment after intensive therapy and autologous stem cell transplantation for relapsing lymphoma. Preliminary results of an international randomized study on 199 patients. Blood 1999; 94: 168a, (abst)
   Web of Science ®Google Scholar